Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × Propofol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 15 Lung Neoplasms 9 Colonic Neoplasms 9 Breast Neoplasms 9 Brain Neoplasms 6 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Respiratory Aspiration 3 Rectal Neoplasms 3 Prostatic Neoplasms 3 Pituitary Neoplasms 3 Neoplastic Cells, Circulating 3 Hypoxia 3 Emergence Delirium 3 Carcinoma, Hepatocellular 3 Agnosia 3 Postoperative Complications 2 Patient Satisfaction 2 Pain 2 Ovarian Neoplasms 2 Melanoma 2 Liver Neoplasms 2 Leukemia 2 Delirium 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Abdominal Neoplasms 2 Uterine Neoplasms 1 Tuberculosis, Pulmonary 1 Thyroid Nodule 1

Interventions

Paclitaxel 79 Carboplatin 63 pembrolizumab 57 Bevacizumab 24 Cisplatin 23 Surveys and Questionnaires 20 Radiotherapy 19 Letrozole 19 Doxorubicin 18 olaparib 17 Megestrol Acetate 17 lenvatinib 16 Specimen Handling 16 dostarlimab 15 Taxes 15 Nivolumab 14 Observation 13 Metformin 13 Magnetic Resonance Spectroscopy 13 Docetaxel 13 Fulvestrant 11 Blood Specimen Collection 11 durvalumab 10 Medroxyprogesterone Acetate 10 Brachytherapy 10 Biopsy 10 temsirolimus 9 abemaciclib 9 Trastuzumab 9 Radiation 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00531349 2016-05-09

ECA/R

The Cleveland Clinic

Phase 3 Withdrawn

Agnosia, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡